Remedium Lifecare Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 14,084.94 million compared to INR 755.8 million a year ago. Revenue was INR 14,113.86 million compared to INR 755.8 million a year ago. Net loss was INR 537.2 million compared to INR 47.81 million a year ago. Basic loss per share from continuing operations was INR 37.305 compared to INR 0.1186 a year ago. Diluted loss per share from continuing operations was INR 37.305 compared to INR 0.1186 a year ago.
For the full year, sales was INR 40,417.07 million compared to INR 5,098.37 million a year ago. Revenue was INR 40,627.88 million compared to INR 5,098.37 million a year ago. Net income was INR 327.3 million compared to INR 54.26 million a year ago. Basic earnings per share from continuing operations was INR 22.73 compared to INR 0.1346 a year ago. Diluted earnings per share from continuing operations was INR 22.73 compared to INR 0.1346 a year ago.